Suppr超能文献

内质网应激与自噬在非酒精性脂肪性肝病(NAFLD)发病机制中的作用:现有证据和观点。

Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives.

机构信息

Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.

Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK.

出版信息

Curr Obes Rep. 2021 Jun;10(2):134-161. doi: 10.1007/s13679-021-00431-3. Epub 2021 Mar 22.

Abstract

PURPOSE OF REVIEW

Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease with rising prevalence worldwide. Herein, we provide a comprehensive overview of the current knowledge supporting the role of ER stress and autophagy processes in NAFLD pathogenesis and progression. We also highlight the interrelation between these two pathways and the impact of ER stress and autophagy modulators on NAFLD treatment.

RECENT FINDINGS

The pathophysiological mechanisms involved in NAFLD progression are currently under investigation. The endoplasmic reticulum (ER) stress and the concomitant unfolded protein response (UPR) seem to contribute to its pathogenesis mainly due to high ER content in the liver which exerts significant metabolic functions and can be dysregulated. Furthermore, disruption of autophagy processes has also been identified in NAFLD. The crucial role of these two pathways in NAFLD is underlined by the fact that they have recently emerged as promising targets of therapeutic interventions. There is a greater need for finding the natural/chemical compounds and drugs which can modulate the ER stress pathway and autophagy for the treatment of NAFLD. Clarifying the inter-relation between these two pathways and their interaction with inflammatory and apoptotic mechanisms will allow the development of additional therapeutic options which can better target and reprogram the underlying pathophysiological pathways, aiming to attenuate NAFLD progression.

摘要

目的综述

非酒精性脂肪性肝病(NAFLD)是世界范围内慢性肝病最常见的原因之一,其患病率正在上升。在此,我们全面概述了目前支持内质网应激和自噬过程在 NAFLD 发病机制和进展中的作用的相关知识。我们还强调了这两条途径之间的相互关系,以及内质网应激和自噬调节剂对 NAFLD 治疗的影响。

最新发现

目前正在研究 NAFLD 进展中涉及的病理生理机制。内质网(ER)应激和随之发生的未折叠蛋白反应(UPR)似乎主要由于肝脏中 ER 含量高而导致其发病机制,肝脏具有重要的代谢功能,并且可能失调。此外,自噬过程的破坏也在 NAFLD 中被发现。这两条途径在 NAFLD 中的关键作用体现在它们最近已成为治疗干预的有前途的靶点这一事实上。因此,更需要寻找能够调节内质网应激途径和自噬的天然/化学化合物和药物,以治疗 NAFLD。阐明这两条途径之间的相互关系及其与炎症和凋亡机制的相互作用,将有助于开发其他治疗选择,从而更好地针对潜在的病理生理途径并对其进行重新编程,以减轻 NAFLD 的进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验